New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 13, 2013
12:21 EDTSRPT, MTUDaiichi Sankyo, govt-backed fund to work on muscular dystrophy drug, Nikkei says
Daiichi Sankyo will work with a government-backed fund to develop a cure for a common form of muscular dystrophy, according to a Nikkei report. The new firm will receive funding from the Innovation Network Corp. of Japan and is also expected to received funding from an investment fund managed by Mitsubishi UFJ Financial (MTU). Reference Link
News For SRPT;MTU From The Last 14 Days
Check below for free stories on SRPT;MTU the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 21, 2014
09:01 EDTSRPTSarepta enters into partnership with Flagship Biosciences
Sarepta Therapeutics and Flagship Biosciences announced a multi-year, multi-product partnership for the development of automated quantitative endpoint measurements in muscular dystrophy to support the advancement of Sarepta’s Duchenne muscular dystrophy drug pipeline, including its lead candidate, eteplirsen. This newly established collaboration with Flagship demonstrates Sarepta’s commitment to enhancing the objective measurement of dystrophin in tissue samples for its growing pipeline of RNA-based therapeutics to treat DMD.
August 20, 2014
06:17 EDTMTUCitigroup looks to sell Japanese retail banking unit, Reuters says
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use